[HTML][HTML] Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast …
I Stückrath, B Rack, W Janni, B Jäger, K Pantel… - Oncotarget, 2015 - ncbi.nlm.nih.gov
I Stückrath, B Rack, W Janni, B Jäger, K Pantel, H Schwarzenbach
Oncotarget, 2015•ncbi.nlm.nih.govAberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are
associated with lymph node metastasis and receptor status of breast cancer patients - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI
Homepage Main Content Main Navigation Search PMC Full-Text Archive Search in PMC
Advanced Search User Guide Journal List Oncotarget v.6(15); 2015 May 30 PMC4537022
Other Formats PDF (1.3M) Actions Cite Collections Share Permalink Copy RESOURCES …
associated with lymph node metastasis and receptor status of breast cancer patients - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI
Homepage Main Content Main Navigation Search PMC Full-Text Archive Search in PMC
Advanced Search User Guide Journal List Oncotarget v.6(15); 2015 May 30 PMC4537022
Other Formats PDF (1.3M) Actions Cite Collections Share Permalink Copy RESOURCES …
Abstract
Within the multicenter SUCCESS trial, we investigated the association of plasma microRNAs with different subtypes of invasive breast cancer.
ncbi.nlm.nih.gov